The Economics of Indication-Based Drug Pricing
The article presents the authors' views on the economics of pricing pharmaceutical treatments and medical devices based on indication of their utilization.
The article presents the authors' views on the economics of pricing pharmaceutical treatments and medical devices based on indication of their utilization.
This paper quantitatively examines the intergenerational effects of girl child marriage, or the developmental and health outcomes of children born to women who marry before age 18.
Holding orders help transition admitted emergency department (ED) patients to hospital beds.
More than fifty years after the passage of the Civil Rights Act of 1964, health care for racial and ethnic minorities remains in many ways separate and unequal in the United States.
Introduction Previous work has shown poisoning-related emergency department (ED) visits are increasing, and these visits are resource-intensive.
The article focuses on health policy regarding the clinical trials which are commonly associated with drugs and devices with the degree of cost sharing borne by the patient or the scope of covered ser
In early May, the U.S.
President Donald Trump has named Scott Gottlieb as his nominee to be the next commissioner of the Food and Drug Administration (FDA).
Many public and private efforts in coming years will focus on research in precision medicine, developing biomarkers to indicate which patients are likely to benefit from a certain treatment so that ot
Get smart & reliable public policy insights right in your inbox.